Literature DB >> 21646236

Carotid endarterectomy is superior to carotid angioplasty and stenting for perioperative and long-term results.

Shipra Arya1, Iraklis I Pipinos, Nitin Garg, Jason Johanning, Thomas G Lynch, G Matthew Longo.   

Abstract

OBJECTIVE: Carotid angioplasty and stenting (CAS) has challenged carotid endarterectomy (CEA) as the therapy of choice for carotid disease. This meta-analysis aims at summarizing the most current body of evidence.
METHODS: All prospective, controlled clinical trials comparing CEA versus CAS were included. The outcome measures of interest were relative risk (RR) of 30-day stroke, 30-day stroke/death, long-term risk of stroke, and risk of restenosis.
RESULTS: The RR of 30-day stroke for CAS was 1.6 times that of CEA (RR 1.6; 95%CI 1.2-2.0, P = .001). The 30-day RR of stroke/death was 1.5 times higher for CAS (RR 1.5; 95%CI 1.1-2.1, P = .008). There was a higher risk of long-term stroke (RR 1.2; 95%CI 1.0-1.5, P = .043). The risk of restenosis was twice for CAS (RR 1.8; 95%CI 1.1-3.1, P = .04).
CONCLUSION: The 30-day RR of stroke, stroke/death, long-term risk of stroke, and risk of restenosis are consistently higher for carotid artery stenting (CAS).

Entities:  

Mesh:

Year:  2011        PMID: 21646236     DOI: 10.1177/1538574411407083

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  Intraoperative blood transfusion of one or two units of packed red blood cells is associated with a fivefold risk of stroke in patients undergoing elective carotid endarterectomy.

Authors:  Chen Rubinstein; Daniel L Davenport; Rebekah Dunnagan; Sibu P Saha; Victor A Ferraris; Eleftherios S Xenos
Journal:  J Vasc Surg       Date:  2013-02       Impact factor: 4.268

Review 2.  The management of carotid restenosis: a comprehensive review.

Authors:  Francesco Stilo; Nunzio Montelione; Rosalinda Calandrelli; Marisa Distefano; Francesco Spinelli; Vincenzo Di Lazzaro; Fabio Pilato
Journal:  Ann Transl Med       Date:  2020-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.